Salem Salem

529 total citations
38 papers, 386 citations indexed

About

Salem Salem is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Salem Salem has authored 38 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 11 papers in Pathology and Forensic Medicine and 11 papers in Cancer Research. Recurrent topics in Salem Salem's work include Genetic factors in colorectal cancer (7 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer-related molecular mechanisms research (4 papers). Salem Salem is often cited by papers focused on Genetic factors in colorectal cancer (7 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer-related molecular mechanisms research (4 papers). Salem Salem collaborates with scholars based in Egypt, United States and Jordan. Salem Salem's co-authors include Abdel‐Rahman N. Zekri, Marwa Hussein, Abeer A. Bahnassy, Mona S. Abdellateif, N ALI, Marwa Mohanad, Ahmed A. Zeeneldin, Nelly Alieldin, Samia A. Shouman and Maggie Abbassi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer.

In The Last Decade

Salem Salem

36 papers receiving 378 citations

Peers

Salem Salem
Marwa Hussein Egypt
Xianjun Lao China
Inuk Zandvakili United States
Rille Pihlak United Kingdom
Kaibo Guo China
Valeria Sanna Italy
Nanya Wang China
Sujata Biswas United Kingdom
Shi Yang China
Marwa Hussein Egypt
Salem Salem
Citations per year, relative to Salem Salem Salem Salem (= 1×) peers Marwa Hussein

Countries citing papers authored by Salem Salem

Since Specialization
Citations

This map shows the geographic impact of Salem Salem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salem Salem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salem Salem more than expected).

Fields of papers citing papers by Salem Salem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salem Salem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salem Salem. The network helps show where Salem Salem may publish in the future.

Co-authorship network of co-authors of Salem Salem

This figure shows the co-authorship network connecting the top 25 collaborators of Salem Salem. A scholar is included among the top collaborators of Salem Salem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salem Salem. Salem Salem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salem, Salem, et al.. (2025). The nephroprotective effect of metformin with cisplatin in bladder cancer: randomized clinical trial. International Urology and Nephrology. 57(11). 3611–3624.
2.
3.
Hussein, Marwa, et al.. (2023). Rebound increase in microRNA levels at the end of 5-FU-based therapy in colorectal cancer patients. Scientific Reports. 13(1). 14237–14237. 6 indexed citations
4.
Salem, Salem, et al.. (2023). Determination of Capecitabine and Its Metabolites in Plasma of Egyptian Colorectal Cancer Patients. SHILAP Revista de lepidopterología. 4(4). 397–414.
5.
Waked, Imam, Kakil Ibrahim Rasul, Wael Abdel‐Razek, et al.. (2023). Multidisciplinary consensus recommendations for management of hepatocellular carcinoma in Middle East and North Africa region. Liver International. 43(10). 2062–2077. 5 indexed citations
6.
Salem, Salem, et al.. (2023). The Clinical Significance of Septin 9 and Colon Cancer Specific Antigen-2 (CCSA-2) in Colorectal Cancer. Asian Pacific Journal of Cancer Prevention. 24(3). 1027–1036. 2 indexed citations
7.
Zekri, Abdel‐Rahman N., Mohamed Ragab, Marwa Mohanad, et al.. (2022). Estrogen Receptor Gene Polymorphism as a Possible Genetic Risk Factor for Treatment Response in ER-Positive Breast Cancer Patients. Biochemical Genetics. 60(6). 1963–1985. 3 indexed citations
8.
Zekri, Abdel‐Rahman N., et al.. (2022). The prognosis of lipid reprogramming with the HMG-CoA reductase inhibitor, rosuvastatin, in castrated Egyptian prostate cancer patients: Randomized trial. PLoS ONE. 17(12). e0278282–e0278282. 3 indexed citations
9.
Salem, Salem, et al.. (2021). The Clinical Significance of Promoter Methylation of Fluoropyrimidine Metabolizing and Cyclooxygenase Genes in Colorectal Cancer. SHILAP Revista de lepidopterología. 14. 2000628343–2000628343. 2 indexed citations
10.
Salem, Salem, et al.. (2021). Fluoropyrimdine therapy induced alterations in interleukins expression in colorectal cancer patients. International Journal of Immunopathology and Pharmacology. 35. 3938478924–3938478924. 1 indexed citations
11.
Abdellateif, Mona S., et al.. (2020). The Prognostic Significance of 5-Fluorouracil Induced Inflammation and Immuno-Modulation in Colorectal Cancer Patients. Journal of Inflammation Research. Volume 13. 1245–1259. 10 indexed citations
12.
Mahfouz, Soheir, et al.. (2019). Role of low level laser in ameliorating the damaging effects of gamma irradiation on mice liver. Iranian Journal of radiation research. 17(1). 97–109. 2 indexed citations
13.
Bahnassy, Abeer A., Salem Salem, Mohammad Elsayed, et al.. (2018). MiRNAs as molecular biomarkers in stage II egyptian colorectal cancer patients. Experimental and Molecular Pathology. 105(3). 260–271. 15 indexed citations
14.
Salem, Salem, et al.. (2018). Impact of Global DNA Methylation in Treatment Outcome of Colorectal Cancer Patients. Frontiers in Pharmacology. 9. 1173–1173. 32 indexed citations
15.
Zeeneldin, Ahmed A., et al.. (2014). Treatment outcomes of female germ cell tumors: The Egyptian National Cancer Institute experience. Journal of the Egyptian National Cancer Institute. 26(2). 103–108. 4 indexed citations
16.
Alieldin, Nelly, et al.. (2013). Age at diagnosis in women with non-metastatic breast cancer: Is it related to prognosis?. Journal of the Egyptian National Cancer Institute. 26(1). 23–30. 26 indexed citations
17.
Zeeneldin, Ahmed A., et al.. (2013). Transarterial chemoembolization for the treatment of hepatocellular carcinoma: A single center experience including 221 patients. Journal of the Egyptian National Cancer Institute. 25(3). 143–150. 14 indexed citations
18.
19.
Bahnassy, Abeer A., Abdel‐Rahman N. Zekri, Samah A. Loutfy, et al.. (2011). The role of cyclins and cyclin dependent kinases in development and progression of hepatitis C virus-genotype 4-associated hepatitis and hepatocellular carcinoma. Experimental and Molecular Pathology. 91(2). 643–652. 8 indexed citations
20.
El-Serafi, Mostafa, Abeer A. Bahnassy, N ALI, et al.. (2010). The prognostic value of c‐Kit, K‐ras codon 12, and p53 codon 72 mutations in Egyptian patients with stage II colorectal cancer. Cancer. 116(21). 4954–4964. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marwa Hussein Breakdown of academic impact, for papers by Xianjun Lao Breakdown of academic impact, for papers by Inuk Zandvakili Breakdown of academic impact, for papers by Rille Pihlak Breakdown of academic impact, for papers by Kaibo Guo Breakdown of academic impact, for papers by Valeria Sanna Breakdown of academic impact, for papers by Nanya Wang Breakdown of academic impact, for papers by Sujata Biswas Breakdown of academic impact, for papers by Shi Yang
Rankless by CCL
2026